Orion, FI0009014377

Orion Stock - Sunday background on the Finnish pharma group

22.06.2026 - 01:29:11 | ad-hoc-news.de

Orion stock gets a Sunday background treatment today. The Finnish pharmaceutical group is best known for its Parkinson’s drug Stalevo and a broad Nordic prescription portfolio. This overview summarizes the company’s setup, history and current market profile.

Orion, FI0009014377
Orion, FI0009014377

Edited by ad hoc news Background & Management Desk. Verified prior to publication on 06/21/2026, 23:28 UTC. Details in the imprint.

Orion (FI0009014377) is a Finnish pharmaceutical company with a long history in prescription drugs and animal health products. With no fresh market-moving news from investor relations or major wires today, this Sunday piece focuses on background and management.

Go deeper

Background and price data on Orion

Further regulatory filings, financial reports and corporate presentations on Orion are available on the company’s investor pages and in the ad-hoc-news.de Orion topic hub.

Orion’s position in Nordic pharma

Orion is headquartered in Espoo, Finland and is one of the country’s best-known listed pharmaceutical groups. The company develops, manufactures and markets human prescription drugs, self-care products and active pharmaceutical ingredients.

Its geographic core remains the Nordic region and selected European markets, with some products distributed more broadly through partners. Orion reports in euros and is listed on Nasdaq Helsinki.

Sunday background on the company

Founded in 1917, Orion has more than a century of operating history in pharmaceuticals and healthcare products. Over the decades it has moved from simple formulations to complex prescription drugs and veterinary medicines.

The group structure today covers several business areas, including Innovative Medicines, Branded Products, Generics and Consumer Health, and Animal Health, each contributing to revenue and earnings.

What the company sells

Orion’s product portfolio spans central nervous system drugs such as Stalevo for Parkinson’s disease, various cancer therapies, inhalers for asthma and COPD, and a wide range of generics and self-care products. The company also supplies veterinary products for companion and production animals.

Where the stock trades today

The shares of Orion (FI0009014377) trade on Nasdaq Helsinki; the latest reliably verifiable price data were not available at press time, so no current quote is stated here.

Key facts on Orion stock

  • Company: Orion Oyj
  • ISIN: FI0009014377
  • Ticker: ORNBV
  • Venue: Nasdaq Helsinki
  • Sector / Industry: Health Care - Pharmaceuticals

More on Orion stock on social media

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.

en | FI0009014377 | ORION | boerse | 69599360 | bgmi